Founded in 2017, Remedico operates in Health Tech industry. Initially focusing on providing remote skin care consultations through a mobile app, the company has evolved by integrating AI-driven diagno...
Funding stage:
Seed
Last funding:
02/02/2021
Total funding:
$1.05 Mn+
Revenue:
Investors
Employee count:
11
Last 90d
11
Last 90d
Glassdoor Rating:
Remedico: Cap Table Highlights
A snapshot of cap table and shareholder metrics
Total Shareholders84
Latest Filing Date13 Feb 2022- Funding Events6
Event-Based View
Event-Based detailed View by Filings
FAQs on Cap Table of Remedico
As of 14 February 2022, Remedico's equity is held by 84 shareholders, with the top three being Ranjit Bhatia, Parkview Health, and Vaibhav Dayal.
Ranjit Bhatia holds the largest stake in Remedico at 27.0% as of 14 February 2022.
As of 14 February 2022, founders collectively hold 37.7% equity in Remedico.
As of 14 February 2022, investors collectively hold 41.6% equity in Remedico.
Disclaimer
Inc42 Datalabs consolidates intelligence from public records, statutory filings, proprietary research, and vetted third‑party datasets. All information is provided as is—please run your own checks before acting on it. Inc42 Datalabs bears no responsibility for decisions or outcomes based on this data.
Quick Links